Study explores industry connections on guidelines committees

08/15/2013 | MedPage Today (free registration)

About 75% of the members of panels setting definitions and diagnosis guidelines for 14 diseases had connections to drugmakers marketing or developing products for the same conditions, a study published in PLOS Medicine found. Members of 12 panels disclosed ties to more than one company, and only the panel changing the definition of type 2 diabetes disclosed no financial ties, researchers found.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY